Emerald Foundation Inc | Foundation Profile
GrantBay analyzes IRS Form 990-PF data to help grant seekers find fit funders like Emerald Foundation Inc. Data shown is extracted from Form 990-PF filings.
EIN: 13-3912580
Foundation Overview
Based in New York, NY, Emerald Foundation Inc has awarded 201 grants totaling $15,342,500 to organizations in New York, Pennsylvania and 10 other states, plus international recipients. Individual grants range from $5,000 to $150,000, with a median award of $75,000.
Latest Tax Year
2024
Total Giving (all years)
$15,342,500
Total Assets
$29,342,456
Median Grant (all grants)
$75,000
Latest Form 990-PF Snapshot
Total Grants
31
Median Grant
$50,000
% Median Grant Growth
+14%
(vs previous year)
Data extracted from IRS Form 990-PF filings. Last filing year:
March 2026
Foundation Intelligence
Advanced analytics and strategic insights to help nonprofit organizations assess grant opportunities and optimize their application strategies
New Applicant Friendliness
Growth-Minded: 58%
18 of 31 recipients (58%) were new grantees. Foundation actively seeks new partnerships to expand impact. Fresh approaches and innovative programs receive serious consideration.
Geographic Focus
Massachusetts
Grants are geographically diversified with 25% in Massachusetts and funding distributed across 17 total locations. This foundation values broad geographic impact and diverse community partnerships. Within Massachusetts, funding concentrates in Cambridge (70%), Boston (30%).
Funding Trajectory
-6%
Stable funding levels with 6% change over 8 years indicate consistent grant-making capacity and predictable philanthropic resources. This stability suggests reliable ongoing funding opportunities.
Program Areas
Healthcare + 4 others
Diversified giving across multiple program areas with primary emphasis on healthcare (62%). This broad approach suggests openness to various causes and innovative cross-sector solutions.
Where is The Money Going?
Loading geographic data...
Loading chart...
Loading chart...
Loading chart...
Grants & Funding
Analyzing past grantees provides valuable insights into Emerald Foundation Inc's funding preferences, organizational priorities, and grant making patterns. This historical data helps potential applicants understand the foundation's strategic focus and identify successful funding approaches.
| Name | Amount | Location | Purpose | Year |
|---|---|---|---|---|
| California Insitute Of Technology | $37,500 | Pasadena, CA, US | To Develop Interpretable Machine Learning Methods That Link Spatial Phenotypes In Imaging Data Of Solid Tumors With Patient Outcomes. | 2024 |
| John Hopkins University | $37,500 | Baltimore, MD, US | To Use Tumor Organoid And Mouse Models To Determine How Loss Of Claudin Proteins Impacts Tumor Invasion And Metastasis. | 2024 |
| Dana-farber Cancer Institute | $50,000 | Boston, MA, US | To Map The Transcriptional And Protein Changes Induced By Lactate And Identify The Mechanisms That Cause Nk Suppression, On Both Nk And Tumor Cells, Using High-throughput And Unbiased Approaches. | 2024 |
| University Of Maryland Sch Of Medic | $75,000 | Baltimore, MD, US | To Investigate The Regulation Of Treg Lymphatic Tumor Migration And The Interaction Among Tregs, Lymphatic Endothelial Cells, And Tumors To Develop Strategies Of Delivering Targeted Therapies Locally Instead Of Systemically. | 2024 |
| Massachusetts Institute Of Technolo | $75,000 | Cambridge, MA, US | To Enhance Nanoparticle Accumulation In Desired Cell Types To Develop More Effective And Safer Targeted Nanotherapies. | 2024 |
| University Of Maryland Sch Of Medic | $75,000 | Baltimore, MD, US | To Investigate The Regulation Of Treg Lymphatic Tumor Migration And The Interaction Among Tregs, Lymphatic Endothelial Cells, And Tumors To Develop Strategies Of Delivering Targeted Therapies Locally Instead Of Systemically. | 2024 |
| Weill Cornell Medicine | $37,500 | New York, NY, US | To Characterize Exosomes From Nave And Tumor-educated Platelets And Determine Their Contribution To Metastatic Dormancy And Recurrence. | 2024 |
| Fox Chase Cancer Center | $37,500 | Philadelphia, PA, US | To Investigate The Role Of Brg1-dependent Epigenetic Regulation On Pdac Fibroblast Pro-tumorigenic Functions. | 2024 |
| Whitehead Inst For Biomedical Resea | $50,000 | Cambridge, MA, US | To Uncover The Set Of Cell-surface Proteins That Mediate Essential Interactions Between Pdac Cells And Their Microenvironment. | 2024 |
| John Hopkins University | $50,000 | Baltimore, MD, US | To Investigate How The Colon Microbiota And Host Genetics Intersect To Alter Responsiveness To Immunotherapy In Colorectal Cancer. | 2024 |
| Salk Institute For Biological Studi | $50,000 | La Jolla, CA, US | To Use Innovative Cell Biology Techniques Coupled With Genomics To Investigate The Role Of Mitochondrial-derived Vesicles In Cancer Cell Metabolism. | 2024 |
| University Of Kentucky | $50,000 | Lexington, KY, US | To Understand How Maladaptive Changes To The Integrated Stress Response Pathway Alter The Force Generating Ability Of Human Heart Cells And Determine If Pharmacological Manipulation Can Rescue Cardiomyocyte Function. | 2024 |
| California Insitute Of Technology | $37,500 | Pasadena, CA, US | To Develop Interpretable Machine Learning Methods That Link Spatial Phenotypes In Imaging Data Of Solid Tumors With Patient Outcomes. | 2024 |
| Salk Institute For Bio Studies | $50,000 | La Jolla, CA, US | To Use Innovative Cell Biology Techniques Coupled With Genomics To Investigate The Role Of Mitochondrial-derived Vesicles In Cancer Cell Metabolism. | 2024 |
| Whitehead Inst For Biomedical Resea | $50,000 | Cambridge, MA, US | To Identify Molecular Mechanisms That Help Anaerobes Cope With Oxygen Exposure And/or Oxidative Stress. | 2024 |
| Whitehead Inst For Biomedical Resea | $50,000 | Cambridge, MA, US | To Identify Molecular Mechanisms That Help Anaerobes Cope With Oxygen Exposure And/or Oxidative Stress. | 2024 |
| Inserm Dr Grand Ouest | $50,000 | Nantes, Cedex 1, FR | To Determine The Mechanism Through Which Breast Cancer Cell Clusters Dissociate Into Single Cells And Proliferate At Distant Sites And To Determine The Impact Of The New Environment On Metastasis Formation. | 2024 |
| Who We Play For Inc | $37,500 | Cocoa Beach, FL, US | To Screen Young Students For Previously Undiagnosed Heart Ailments And Generate Data That Can Be Used To Train Ai Programs To Better Evaluate Electrocardiograms. | 2024 |
| Nyu School Of Medicine | $75,000 | New York, NY, US | To Examine The Cellular Mechanisms Through Which Dendrite-centric Alzheimer's Disease Pathologies Result In Cognitive Dysfunction And Hyper-excitability. | 2024 |
| Harvard Medical School | $37,500 | Boston, MD, US | To Study How Slc7a5 Regulates Metabolic Reprogramming And Signaling Pathways That Enable Cancer Cells To Survive Cdk4/6i Treatment. | 2024 |
| University Of Pennsylvania | $50,000 | Philadelphia, PA, US | To Understand The Molecular Mechanism Underlying Immunosuppression And Immunoactivation And Develop New Treatment Strategies For Hepatic Malignancies. | 2024 |
| Weill Cornell Medicine | $75,000 | New York, NY, US | To Identify Regulators Of Lineage Reversion That Impact Resistance To Wnt-targeted Therapies In Colorectal Cancer. | 2024 |
| Cancer Research Uk Cruk | $10,000 | London, Foreign, UK | Sponsorship Of Cruk Conferences Sponsorship Fee - Travel Bursaries For Those Attending The Black In Cancer Conference (2022). | 2024 |
| Dana-farber Cancer Institute | $50,000 | Boston, MA, US | To Map The Transcriptional And Protein Changes Induced By Lactate And Identify The Mechanisms That Cause Nk Suppression, On Both Nk And Tumor Cells, Using High-throughput And Unbiased Approaches. | 2024 |
| Harvard Medical School | $37,500 | Boston, MA, US | To Study How Slc7a5 Regulates Metabolic Reprogramming And Signaling Pathways That Enable Cancer Cells To Survive Cdk4/6i Treatment. | 2024 |
| Massachusetts Institute Of Technolo | $87,500 | Cambridge, MA, US | To Study How Ferroptosis-based Strategies Can Enhance The Efficacy Of Immunotherapies In Breast Cancer. | 2024 |
| Nyu School Of Medicine | $37,500 | New York, NY, US | To Characterize Interactions Between Proteins That Associate Only With The Kras4a Isoform To Identifying Pathways That Can Be Rationally Targeted To Achieve A More Comprehensive Interruption Of Kras Stimulation. | 2024 |
| University Of Pennsylvania | $50,000 | Philadelphia, PA, US | To Understand The Molecular Mechanism Underlying Immunosuppression And Immunoactivation And Develop New Treatment Strategies For Hepatic Malignancies. | 2024 |
| University Of Kentucky | $50,000 | Lexington, KY, US | To Understand How Maladaptive Changes To The Integrated Stress Response Pathway Alter The Force Generating Ability Of Human Heart Cells And Determine If Pharmacological Manipulation Can Rescue Cardiomyocyte Function. | 2024 |
| University Of Michigan | $50,000 | Ann Arbor, MI, US | To Use Tumor Organoid And Mouse Models To Determine How Loss Of Claudin Proteins Impacts Tumor Invasion And Metastasis. | 2024 |
| Weill Cornell Medicine | $37,500 | New York, NY, US | To Characterize Exosomes From Nave And Tumor-educated Platelets And Determine Their Contribution To Metastatic Dormancy And Recurrence. | 2024 |
| Ca Institute Of Technology | $37,500 | Pasadena, CA, US | To Develop Interpretable Machine Learning Methods That Link Spatial Phenotypes In Imaging Data Of Solid Tumors With Patient Outcomes. | 2023 |
| Institute For Cancer Research | $37,500 | Philadelphia, PA, US | To Investigate The Role Of Brg1-dependent Epigenetic Regulation On Pdac Fibroblast Pro-tumorigenic Functions. | 2023 |
| John Hopkins University | $100,000 | Baltimore, MD, US | To Investigate How The Colon Microbiota And Host Genetics Intersect To Alter Responsiveness To Immunotherapy In Colorectal Cancer. | 2023 |
| Dana-farber Cancer Institute | $100,000 | Boston, MA, US | To Map The Transcriptional And Protein Changes Induced By Lactate And Identify The Mechanisms That Cause Nk Suppression, On Both Nk And Tumor Cells, Using High-throughput And Unbiased Approaches. | 2023 |
| Ma Institute Of Technology | $37,500 | Cambridge, MA, US | To Develop A High-throughput Single-cell Gro-seq Assay To Examine The Tumor Microenvironment Established By Mutant-p53 And Decipher The Gene Regulatory Networks Underlying Pdac's Intransigence To Immunotherapies. | 2023 |
| University Of Md Baltimore Foundati | $150,000 | Baltimore, MD, US | To Investigate The Regulation Of Treg Lymphatic Tumor Migration And The Interaction Among Tregs, Lymphatic Endothelial Cells, And Tumors To Develop Strategies Of Delivering Targeted Therapies Locally Instead Of Systemically. | 2023 |
| Ma Institute Of Technology | $37,500 | Cambridge, MA, US | To Develop A High-throughput Single-cell Gro-seq Assay To Examine The Tumor Microenvironment Established By Mutant-p53 And Decipher The Gene Regulatory Networks Underlying Pdac's Intrasigence To Immunotherapies. | 2023 |
| Ma Institute Of Technology | $75,000 | Cambridge, MA, US | To Enhance Nanoparticle Accumulation In Desired Cell Types To Develop More Effective And Safer Targeted Nanotherapies. | 2023 |
| Institute For Cancer Research | $37,500 | Philadelphia, PA, US | To Investigate The Role Of Brg1-dependent Epigenetic Regulation On Pdac Fibroblast Pro-tumorigenic Functions. | 2023 |
| Whitehead Institute For Biomed | $50,000 | Cambridge, MA, US | To Uncover The Set Of Cell-surface Proteins That Mediate Essential Interactions Between Pdac Cells And Their Microenvironment. | 2023 |
| John Hopkins University | $50,000 | Baltimore, MD, US | To Investigate How The Colon Microbiota And Host Genetics Intersect To Alter Responsiveness To Immunotherapy In Colorectal Cancer. | 2023 |
| Salk Institute For Bio Studies | $50,000 | La Jolla, CA, US | To Use Innovative Cell Biology Techniques Coupled With Genomics To Investigate The Role Of Mitochondrial-derived Vesicles In Cancer Cell Metabolism. | 2023 |
| John Hopkins University | $37,500 | Baltimore, MD, US | To Use Tumor Organoid And Mouse Models To Determine How Loss Of Claudin Proteins Impacts Tumor Invasion And Metastasis. | 2023 |
| University Of Ky | $100,000 | Lexington, KY, US | To Understand How Maladaptive Changes To The Integrated Stress Response Pathway Alter The Force Generating Ability Of Human Heart Cells And Determine If Pharmacological Manipulation Can Rescue Cardiomyocyte Function. | 2023 |
| Ca Insitute Of Technology | $37,500 | Pasadena, CA, US | To Develop Interpretable Machine Learning Methods That Link Spatial Phenotypes In Imaging Data Of Solid Tumors With Patient Outcomes. | 2023 |
| John Hopkins University | $37,500 | Baltimore, MD, US | To Use Tumor Organoid And Mouse Models To Determine How Loss Of Claudin Proteins Impacts Tumor Invasion And Metastasis. | 2023 |
| Salk Institute For Bio Studies | $50,000 | La Jolla, CA, US | To Use Innovative Cell Biology Techniques Coupled With Genomics To Investigate The Role Of Mitochondrial-derived Vesicles In Cancer Cell Metabolism. | 2023 |
| President Fellows Of Harvard | $37,500 | Boston, MA, US | To Study How Slc7a5 Regulates Metabolic Reprogramming And Signaling Pathways That Enable Cancer Cells To Survive Cdk4/6i Treatment. | 2023 |
| Whitehead Institute For Biomed | $50,000 | Cambridge, MA, US | To Uncover The Set Of Cell-surface Proteins That Mediate Essential Interactions Between Pdac Cells And Their Microenvironment. | 2023 |
| Whitehead Institute For Biomed | $37,500 | Cambridge, MA, US | To Study How Ferroptosis-based Strategies Can Enhance The Efficacy Of Immunotherapies In Breast Cancer. | 2023 |
| Inserm Dr Grand Ouest | $100,000 | Nantes, Pays de la loire, FR | To Determine The Mechanism Through Which Breast Cancer Cell Clusters Dissociate Into Single Cells And Proliferate At Distant Sites And To Determine The Impact Of The New Environment On Metastasis Formation. | 2023 |
| Joan Sanford I Weill Medical | $75,000 | New York, NY, US | To Identify Regulators Of Lineage Reversion That Impact Resistance To Wnt-targeted Therapies In Colorectal Cancer. | 2023 |
| Joan Sanford I Weill Medical | $37,500 | New York, NY, US | To Characterize Exosomes From Nave And Tumor-educated Platelets And Determine Their Contribution To Metastatic Dormancy And Recurrence. | 2023 |
| Who We Play For Inc | $37,500 | Cocoa Beach, FL, US | To Screen Young Students For Previously Undiagnosed Heart Ailments And Generate Data That Can Be Used To Train Ai Programs To Better Evaluate Electrocardiograms. | 2023 |
| Ca Institute Of Technology | $37,500 | Pasadena, CA, US | To Develop Interpretable Machine Learning Methods That Link Spatial Phenotypes In Imaging Data Of Solid Tumors With Patient Outcomes. | 2023 |
| Institute For Cancer Research | $37,500 | Philadelphia, PA, US | To Investigate The Role Of Brg1-dependent Epigenetic Regulation On Pdac Fibroblast Pro-tumorigenic Functions. | 2023 |
| John Hopkins University | $100,000 | Baltimore, MD, US | To Investigate How The Colon Microbiota And Host Genetics Intersect To Alter Responsiveness To Immunotherapy In Colorectal Cancer. | 2023 |
| Dana-farber Cancer Institute | $100,000 | Boston, MA, US | To Map The Transcriptional And Protein Changes Induced By Lactate And Identify The Mechanisms That Cause Nk Suppression, On Both Nk And Tumor Cells, Using High-throughput And Unbiased Approaches. | 2023 |
| Ma Institute Of Technology | $37,500 | Cambridge, MA, US | To Develop A High-throughput Single-cell Gro-seq Assay To Examine The Tumor Microenvironment Established By Mutant-p53 And Decipher The Gene Regulatory Networks Underlying Pdac's Intransigence To Immunotherapies. | 2023 |
| University Of Md Baltimore Foundati | $150,000 | Baltimore, MD, US | To Investigate The Regulation Of Treg Lymphatic Tumor Migration And The Interaction Among Tregs, Lymphatic Endothelial Cells, And Tumors To Develop Strategies Of Delivering Targeted Therapies Locally Instead Of Systemically. | 2023 |
| Ma Institute Of Technology | $37,500 | Cambridge, MA, US | To Develop A High-throughput Single-cell Gro-seq Assay To Examine The Tumor Microenvironment Established By Mutant-p53 And Decipher The Gene Regulatory Networks Underlying Pdac's Intrasigence To Immunotherapies. | 2023 |
| Ma Institute Of Technology | $75,000 | Cambridge, MA, US | To Enhance Nanoparticle Accumulation In Desired Cell Types To Develop More Effective And Safer Targeted Nanotherapies. | 2023 |
| Institute For Cancer Research | $37,500 | Philadelphia, PA, US | To Investigate The Role Of Brg1-dependent Epigenetic Regulation On Pdac Fibroblast Pro-tumorigenic Functions. | 2023 |
| Whitehead Institute For Biomed | $50,000 | Cambridge, MA, US | To Uncover The Set Of Cell-surface Proteins That Mediate Essential Interactions Between Pdac Cells And Their Microenvironment. | 2023 |
| John Hopkins University | $50,000 | Baltimore, MD, US | To Investigate How The Colon Microbiota And Host Genetics Intersect To Alter Responsiveness To Immunotherapy In Colorectal Cancer. | 2023 |
| Salk Institute For Bio Studies | $50,000 | La Jolla, CA, US | To Use Innovative Cell Biology Techniques Coupled With Genomics To Investigate The Role Of Mitochondrial-derived Vesicles In Cancer Cell Metabolism. | 2023 |
| John Hopkins University | $37,500 | Baltimore, MD, US | To Use Tumor Organoid And Mouse Models To Determine How Loss Of Claudin Proteins Impacts Tumor Invasion And Metastasis. | 2023 |
| University Of Ky | $100,000 | Lexington, KY, US | To Understand How Maladaptive Changes To The Integrated Stress Response Pathway Alter The Force Generating Ability Of Human Heart Cells And Determine If Pharmacological Manipulation Can Rescue Cardiomyocyte Function. | 2023 |
| Ca Insitute Of Technology | $37,500 | Pasadena, CA, US | To Develop Interpretable Machine Learning Methods That Link Spatial Phenotypes In Imaging Data Of Solid Tumors With Patient Outcomes. | 2023 |
| John Hopkins University | $37,500 | Baltimore, MD, US | To Use Tumor Organoid And Mouse Models To Determine How Loss Of Claudin Proteins Impacts Tumor Invasion And Metastasis. | 2023 |
| Salk Institute For Bio Studies | $50,000 | La Jolla, CA, US | To Use Innovative Cell Biology Techniques Coupled With Genomics To Investigate The Role Of Mitochondrial-derived Vesicles In Cancer Cell Metabolism. | 2023 |
| President Fellows Of Harvard | $37,500 | Boston, MA, US | To Study How Slc7a5 Regulates Metabolic Reprogramming And Signaling Pathways That Enable Cancer Cells To Survive Cdk4/6i Treatment. | 2023 |
| Whitehead Institute For Biomed | $50,000 | Cambridge, MA, US | To Uncover The Set Of Cell-surface Proteins That Mediate Essential Interactions Between Pdac Cells And Their Microenvironment. | 2023 |
| Whitehead Institute For Biomed | $37,500 | Cambridge, MA, US | To Study How Ferroptosis-based Strategies Can Enhance The Efficacy Of Immunotherapies In Breast Cancer. | 2023 |
| Inserm Dr Grand Ouest | $100,000 | Nantes, Pays de la loire, FR | To Determine The Mechanism Through Which Breast Cancer Cell Clusters Dissociate Into Single Cells And Proliferate At Distant Sites And To Determine The Impact Of The New Environment On Metastasis Formation. | 2023 |
| Joan Sanford I Weill Medical | $75,000 | New York, NY, US | To Identify Regulators Of Lineage Reversion That Impact Resistance To Wnt-targeted Therapies In Colorectal Cancer. | 2023 |
| Joan Sanford I Weill Medical | $37,500 | New York, NY, US | To Characterize Exosomes From Nave And Tumor-educated Platelets And Determine Their Contribution To Metastatic Dormancy And Recurrence. | 2023 |
| Who We Play For Inc | $37,500 | Cocoa Beach, FL, US | To Screen Young Students For Previously Undiagnosed Heart Ailments And Generate Data That Can Be Used To Train Ai Programs To Better Evaluate Electrocardiograms. | 2023 |
| Univeristy Of Ca San Francisco | $75,000 | San Francisco, CA, US | To Develop A Small Molecule That Stabilizes Mutant P53 In Cancer And Further Elaborate This Compound With The Ability To Increase Dna Binding Of Bound P53. | 2022 |
| University Of Ca Santa Barbara | $37,500 | Santa Barbara, CA, US | To Understand How Maladaptive Changes To The Integrated Stress Response Pathway Alter The Force Generating Ability Of Human Heart Cells And Determine If Pharmacological Manipulation Can Rescue Cardiomyocyte Function. | 2022 |
| Ca Institute Of Technology | $80,000 | Pasadena, CA, US | To Develop Interpretable Machine Learning Methods That Link Spatial Phenotypes In Imaging Data Of Solid Tumors With Patient Outcomes. | 2022 |
| Institute For Cancer Research | $5,000 | Philadelphia, PA, US | To Investigate The Role Of Brg1-dependent Epigenetic Regulation On Pdac Fibroblast Pro-tumorigenic Functions. | 2022 |
| Rockefeller University | $75,000 | New York, NY, US | To Investigate The Role Of Trna-derived Fragments And The Genes They Regulate In Breast Cancer Progression And Metastasis. | 2022 |
| John Hopkins University | $5,000 | Baltimore, MD, US | To Investigate How The Colon Microbiota And Host Genetics Intersect To Alter Responsiveness To Immunotherapy In Colorectal Cancer. | 2022 |
| Dana-farber Cancer Institute | $100,000 | Boston, MA, US | To Map The Transcriptional And Protein Changes Induced By Lactate And Identify The Mechanisms That Cause Nk Suppression, On Both Nk And Tumor Cells, Using High-throughput And Unbiased Approaches. | 2022 |
| University Of Md Baltimore Foundati | $75,000 | Baltimore, MD, US | To Investigate The Regulation Of Treg Lymphatic Tumor Migration And The Interaction Among Tregs, Lymphatic Endothelial Cells, And Tumors To Develop Strategies Of Delivering Targeted Therapies Locally Instead Of Systemically. | 2022 |
| Ma Institute Of Technology | $37,500 | Cambridge, MA, US | To Develop A High-throughput Single-cell Gro-seq Assay To Examine The Tumor Microenvironment Established By Mutant-p53 And Decipher The Gene Regulatory Networks Underlying Pdac's Intransigence To Immunotherapies. | 2022 |
| University Of Guelph | $100,000 | East Guelph, ONTARIO, CA | To Identify Combinations Of Commercial Bacterial Isolates That Suppress Klebsiella Pneumoniae In The Colon And The Underlying Cooperative Mechanisms Of This Activity. | 2022 |
| University Of Md Baltimore Foundati | $75,000 | Baltimore, MD, US | To Investigate The Regulation Of Treg Lymphatic Tumor Migration And The Interaction Among Tregs, Lymphatic Endothelial Cells, And Tumors To Develop Strategies Of Delivering Targeted Therapies Locally Instead Of Systemically. | 2022 |
| Weill Med College Of Cornell U | $150,000 | New York, NY, US | To Identify Regulators Of Lineage Reversion That Impact Resistance To Wnt-targeted Therapies In Colorectal Cancer. | 2022 |
| Ma Institute Of Technology | $37,500 | Cambridge, MA, US | To Develop A High-throughput Single-cell Gro-seq Assay To Examine The Tumor Microenvironment Established By Mutant-p53 And Decipher The Gene Regulatory Networks Underlying Pdac's Intrasigence To Immunotherapies. | 2022 |
| Ma Institute Of Technology | $150,000 | Cambridge, MA, US | To Enhance Nanoparticle Accumulation In Desired Cell Types To Develop More Effective And Safer Targeted Nanotherapies. | 2022 |
| Institute For Cancer Research | $37,500 | Philadelphia, PA, US | To Investigate The Role Of Brg1-dependent Epigenetic Regulation On Pdac Fibroblast Pro-tumorigenic Functions. | 2022 |
| Whitehead Institute For Biomed | $50,000 | Cambridge, MA, US | To Uncover The Set Of Cell-surface Proteins That Mediate Essential Interactions Between Pdac Cells And Their Microenvironment. | 2022 |
| John Hopkins University | $50,000 | Baltimore, MD, US | To Investigate How The Colon Microbiota And Host Genetics Intersect To Alter Responsiveness To Immunotherapy In Colorectal Cancer. | 2022 |
| Salk Institute For Bio Studies | $50,000 | La Jolla, CA, US | To Use Innovative Cell Biology Techniques Coupled With Genomics To Investigate The Role Of Mitochondrial-derived Vesicles In Cancer Cell Metabolism. | 2022 |
| John Hopkins University | $37,500 | Baltimore, MD, US | To Use Tumor Organoid And Mouse Models To Determine How Loss Of Claudin Proteins Impacts Tumor Invasion And Metastasis. | 2022 |
| University Of Ky | $37,500 | Lexington, KY, US | To Understand How Maladaptive Changes To The Integrated Stress Response Pathway Alter The Force Generating Ability Of Human Heart Cells And Determine If Pharmacological Manipulation Can Rescue Cardiomyocyte Function. | 2022 |
| Univeristy Of Ca San Francisco | $75,000 | San Francisco, CA, US | To Develop A Small Molecule That Stabilizes Mutant P53 In Cancer And Further Elaborate This Compound With The Ability To Increase Dna Binding Of Bound P53. | 2022 |
| University Of Ca Santa Barbara | $37,500 | Santa Barbara, CA, US | To Understand How Maladaptive Changes To The Integrated Stress Response Pathway Alter The Force Generating Ability Of Human Heart Cells And Determine If Pharmacological Manipulation Can Rescue Cardiomyocyte Function. | 2022 |
| Ca Institute Of Technology | $80,000 | Pasadena, CA, US | To Develop Interpretable Machine Learning Methods That Link Spatial Phenotypes In Imaging Data Of Solid Tumors With Patient Outcomes. | 2022 |
| Institute For Cancer Research | $5,000 | Philadelphia, PA, US | To Investigate The Role Of Brg1-dependent Epigenetic Regulation On Pdac Fibroblast Pro-tumorigenic Functions. | 2022 |
| Rockefeller University | $75,000 | New York, NY, US | To Investigate The Role Of Trna-derived Fragments And The Genes They Regulate In Breast Cancer Progression And Metastasis. | 2022 |
| John Hopkins University | $5,000 | Baltimore, MD, US | To Investigate How The Colon Microbiota And Host Genetics Intersect To Alter Responsiveness To Immunotherapy In Colorectal Cancer. | 2022 |
| Dana-farber Cancer Institute | $100,000 | Boston, MA, US | To Map The Transcriptional And Protein Changes Induced By Lactate And Identify The Mechanisms That Cause Nk Suppression, On Both Nk And Tumor Cells, Using High-throughput And Unbiased Approaches. | 2022 |
| University Of Md Baltimore Foundati | $75,000 | Baltimore, MD, US | To Investigate The Regulation Of Treg Lymphatic Tumor Migration And The Interaction Among Tregs, Lymphatic Endothelial Cells, And Tumors To Develop Strategies Of Delivering Targeted Therapies Locally Instead Of Systemically. | 2022 |
| Ma Institute Of Technology | $37,500 | Cambridge, MA, US | To Develop A High-throughput Single-cell Gro-seq Assay To Examine The Tumor Microenvironment Established By Mutant-p53 And Decipher The Gene Regulatory Networks Underlying Pdac's Intransigence To Immunotherapies. | 2022 |
| University Of Guelph | $100,000 | East Guelph, ONTARIO, CA | To Identify Combinations Of Commercial Bacterial Isolates That Suppress Klebsiella Pneumoniae In The Colon And The Underlying Cooperative Mechanisms Of This Activity. | 2022 |
| University Of Md Baltimore Foundati | $75,000 | Baltimore, MD, US | To Investigate The Regulation Of Treg Lymphatic Tumor Migration And The Interaction Among Tregs, Lymphatic Endothelial Cells, And Tumors To Develop Strategies Of Delivering Targeted Therapies Locally Instead Of Systemically. | 2022 |
| Weill Med College Of Cornell U | $150,000 | New York, NY, US | To Identify Regulators Of Lineage Reversion That Impact Resistance To Wnt-targeted Therapies In Colorectal Cancer. | 2022 |
| Ma Institute Of Technology | $37,500 | Cambridge, MA, US | To Develop A High-throughput Single-cell Gro-seq Assay To Examine The Tumor Microenvironment Established By Mutant-p53 And Decipher The Gene Regulatory Networks Underlying Pdac's Intrasigence To Immunotherapies. | 2022 |
| Ma Institute Of Technology | $150,000 | Cambridge, MA, US | To Enhance Nanoparticle Accumulation In Desired Cell Types To Develop More Effective And Safer Targeted Nanotherapies. | 2022 |
| Institute For Cancer Research | $37,500 | Philadelphia, PA, US | To Investigate The Role Of Brg1-dependent Epigenetic Regulation On Pdac Fibroblast Pro-tumorigenic Functions. | 2022 |
| Whitehead Institute For Biomed | $50,000 | Cambridge, MA, US | To Uncover The Set Of Cell-surface Proteins That Mediate Essential Interactions Between Pdac Cells And Their Microenvironment. | 2022 |
| John Hopkins University | $50,000 | Baltimore, MD, US | To Investigate How The Colon Microbiota And Host Genetics Intersect To Alter Responsiveness To Immunotherapy In Colorectal Cancer. | 2022 |
| Salk Institute For Bio Studies | $50,000 | La Jolla, CA, US | To Use Innovative Cell Biology Techniques Coupled With Genomics To Investigate The Role Of Mitochondrial-derived Vesicles In Cancer Cell Metabolism. | 2022 |
| John Hopkins University | $37,500 | Baltimore, MD, US | To Use Tumor Organoid And Mouse Models To Determine How Loss Of Claudin Proteins Impacts Tumor Invasion And Metastasis. | 2022 |
| University Of Ky | $37,500 | Lexington, KY, US | To Understand How Maladaptive Changes To The Integrated Stress Response Pathway Alter The Force Generating Ability Of Human Heart Cells And Determine If Pharmacological Manipulation Can Rescue Cardiomyocyte Function. | 2022 |
| Univeristy Of Ca San Francisco | $75,000 | San Francisco, CA, US | To Develop A Small Molecule That Stabilizes Mutant P53 In Cancer And Further Elaborate This Compound With The Ability To Increase Dna Binding Of Bound P53. | 2022 |
| University Of Ca Santa Barbara | $37,500 | Santa Barbara, CA, US | To Understand How Maladaptive Changes To The Integrated Stress Response Pathway Alter The Force Generating Ability Of Human Heart Cells And Determine If Pharmacological Manipulation Can Rescue Cardiomyocyte Function. | 2022 |
| Ca Institute Of Technology | $80,000 | Pasadena, CA, US | To Develop Interpretable Machine Learning Methods That Link Spatial Phenotypes In Imaging Data Of Solid Tumors With Patient Outcomes. | 2022 |
| Institute For Cancer Research | $5,000 | Philadelphia, PA, US | To Investigate The Role Of Brg1-dependent Epigenetic Regulation On Pdac Fibroblast Pro-tumorigenic Functions. | 2022 |
| Rockefeller University | $75,000 | New York, NY, US | To Investigate The Role Of Trna-derived Fragments And The Genes They Regulate In Breast Cancer Progression And Metastasis. | 2022 |
| John Hopkins University | $5,000 | Baltimore, MD, US | To Investigate How The Colon Microbiota And Host Genetics Intersect To Alter Responsiveness To Immunotherapy In Colorectal Cancer. | 2022 |
| Dana-farber Cancer Institute | $100,000 | Boston, MA, US | To Map The Transcriptional And Protein Changes Induced By Lactate And Identify The Mechanisms That Cause Nk Suppression, On Both Nk And Tumor Cells, Using High-throughput And Unbiased Approaches. | 2022 |
| University Of Md Baltimore Foundati | $75,000 | Baltimore, MD, US | To Investigate The Regulation Of Treg Lymphatic Tumor Migration And The Interaction Among Tregs, Lymphatic Endothelial Cells, And Tumors To Develop Strategies Of Delivering Targeted Therapies Locally Instead Of Systemically. | 2022 |
| Ma Institute Of Technology | $37,500 | Cambridge, MA, US | To Develop A High-throughput Single-cell Gro-seq Assay To Examine The Tumor Microenvironment Established By Mutant-p53 And Decipher The Gene Regulatory Networks Underlying Pdac's Intransigence To Immunotherapies. | 2022 |
| University Of Guelph | $100,000 | East Guelph, ONTARIO, CA | To Identify Combinations Of Commercial Bacterial Isolates That Suppress Klebsiella Pneumoniae In The Colon And The Underlying Cooperative Mechanisms Of This Activity. | 2022 |
| University Of Md Baltimore Foundati | $75,000 | Baltimore, MD, US | To Investigate The Regulation Of Treg Lymphatic Tumor Migration And The Interaction Among Tregs, Lymphatic Endothelial Cells, And Tumors To Develop Strategies Of Delivering Targeted Therapies Locally Instead Of Systemically. | 2022 |
| Weill Med College Of Cornell U | $150,000 | New York, NY, US | To Identify Regulators Of Lineage Reversion That Impact Resistance To Wnt-targeted Therapies In Colorectal Cancer. | 2022 |
| Ma Institute Of Technology | $37,500 | Cambridge, MA, US | To Develop A High-throughput Single-cell Gro-seq Assay To Examine The Tumor Microenvironment Established By Mutant-p53 And Decipher The Gene Regulatory Networks Underlying Pdac's Intrasigence To Immunotherapies. | 2022 |
| Ma Institute Of Technology | $150,000 | Cambridge, MA, US | To Enhance Nanoparticle Accumulation In Desired Cell Types To Develop More Effective And Safer Targeted Nanotherapies. | 2022 |
| Institute For Cancer Research | $37,500 | Philadelphia, PA, US | To Investigate The Role Of Brg1-dependent Epigenetic Regulation On Pdac Fibroblast Pro-tumorigenic Functions. | 2022 |
| Whitehead Institute For Biomed | $50,000 | Cambridge, MA, US | To Uncover The Set Of Cell-surface Proteins That Mediate Essential Interactions Between Pdac Cells And Their Microenvironment. | 2022 |
| John Hopkins University | $50,000 | Baltimore, MD, US | To Investigate How The Colon Microbiota And Host Genetics Intersect To Alter Responsiveness To Immunotherapy In Colorectal Cancer. | 2022 |
| Salk Institute For Bio Studies | $50,000 | La Jolla, CA, US | To Use Innovative Cell Biology Techniques Coupled With Genomics To Investigate The Role Of Mitochondrial-derived Vesicles In Cancer Cell Metabolism. | 2022 |
| John Hopkins University | $37,500 | Baltimore, MD, US | To Use Tumor Organoid And Mouse Models To Determine How Loss Of Claudin Proteins Impacts Tumor Invasion And Metastasis. | 2022 |
| University Of Ky | $37,500 | Lexington, KY, US | To Understand How Maladaptive Changes To The Integrated Stress Response Pathway Alter The Force Generating Ability Of Human Heart Cells And Determine If Pharmacological Manipulation Can Rescue Cardiomyocyte Function. | 2022 |
| Weill Cornell Medicine | $150,000 | New York, NY, US | To Identify Regulators Of Lineage Reversion That Impact Resistance To Wnt-targeted Therapies In Colorectal Cancer. | 2021 |
| Fox Chase Cancer Center | $75,000 | Philadelphia, PA, US | To Investigate The Role Of Brg1-depedent Epigenetic Regulation On Pdac Fibroblast Pro-tumorigenic Functions. | 2021 |
| Brigham And Women's Hospital Inc | $150,000 | Boston, MA, US | To Uncover And Validate Druggable Targets That Can Be Combined With Mek/erk Inhibitors To Treat Ras Pathway-driven Malignancies, Especially Melanoma. | 2021 |
| Dana-farber Cancer Institute | $75,000 | Boston, MA, US | To Optimize Usp8 Inhibitors And Test Their Activity In Models Of Neurodegenerative Disease, Non-small Cell Lung Cancer, And Other Applicable Systems. | 2021 |
| Massachusetts Institute Of Technology | $150,000 | Cambridge, MA, US | To Investigate The Role Of Diet And Nutrient Availability In Tumor Growth, Progression, And Response To Treatment. | 2021 |
| Memorial Sloan-kettering Cancer Center | $75,000 | New York, NY, US | To Investigate The Molecular Mechanisms Underlying How Endgogenous Dna-modifying Enzymes Lead To Cancer Genome Evolution. | 2021 |
| Nyu School Of Medicine | $75,000 | New York, NY, US | To Investigate How Metabolic Rewiring In Distinct Genetic Subtypes Of Lung Cancer Impacts Immune Cell Infiltration And Leads To Immune Evasion. | 2021 |
| Massachusetts Institute Of Technology | $150,000 | Cambridge, MA, US | To Engance Nanoparticle Accumulation In Desired Cell Types To Develop More Effective And Safer Targeted Nanotherapies. | 2021 |
| Whitehead Institute For Biomedical Research | $100,000 | Cambridge, MA, US | To Investigate The Role Of Trna-derived Fragments And The Genes They Regulate In Breast Cancer Progression And Metastasis. | 2021 |
| Salk Institute For Biological Studies | $100,000 | La Jolla, CA, US | To Investigate The Potential Of Ca19-9 As A Therapeutic Target For Pancreatic Cancer Treatment And To Discover Pharmacological Approaches To Blocking Ca19-9 Production In Malignant Cells. | 2021 |
| University Of California San Francisco | $75,000 | San Francisco, CA, US | To Develop A Small Molecule That Stabilizes Mutant P53 In Cancer And Further Elaborate This Compound With The Ability To Increase Dna Binding Of Bound P53. | 2021 |
| Johns Hopkins University | $75,000 | Baltimore, MD, US | To Investigate How The Colon Microbiota And Host Genetics Intersect To Alter Responsiveness To Immunotherapy In Colorectal Cancer. | 2021 |
| University Of Guelph | $100,000 | Guelph, Ontario, CA | To Identify Combinations Of Commercial Bacterial Isolates That Suppress Klebsiella Pneumoniae In The Colon And The Underlying Cooperative Mechanisms Of This Activity. | 2021 |
| Rockefeller Universtity | $75,000 | New York, NY, US | To Investigate The Role Of Trna-derived Fragments And The Genes They Regulate In Breast Cancer Progression And Metastasis. | 2021 |
| Brigham And Women's Hospital Inc | $150,000 | Boston, MA, US | To Uncover And Validate Druggable Targets That Can Be Combined With Mek/erk Inhibitors To Treat Ras Pathway-driven Malignancies, Especially Melanoma. | 2020 |
| Dana-farber Cancer Institute | $75,000 | Boston, MA, US | To Optimize Usp8 Inhibitors And Test Their Activity In Models Of Neurodegenerative Disease, Non-small Cell Lung Cancer, And Other Applicable Systems. | 2020 |
| Massachusetts Institute Of Technology | $150,000 | Cambridge, MA, US | To Investigate The Role Of Diet And Nutrient Availability In Tumor Growth, Progression, And Response To Treatment. | 2020 |
| Memorial Sloan-kettering Cancer Center | $75,000 | New York, NY, US | To Investigate The Molecular Mechanisms Underlying How Endgogenous Dna-modifying Enzymes Lead To Cancer Genome Evolution. | 2020 |
| Nyu School Of Medicine | $75,000 | New York, NY, US | To Investigate How Metabolic Rewiring In Distinct Genetic Subtypes Of Lung Cancer Impacts Immune Cell Infiltration And Leads To Immune Evasion. | 2020 |
| Regents Of The University Of California | $150,000 | La Jolla, CA, US | To (1) Define A Microbiome Growth Curce In Healthy Children, (2) Determine When And Why Deviation From This Curve Occurs, And (3) Investigate Known, As Well As Discover New, Microbiome-linked Disorders And Relationships Among Them, And Analyze Microbiome Associations With Clinical Presentations Of Covid-19. | 2020 |
| Rockefeller University | $150,000 | New York, NY, US | To Investigate The Role Of Trna-derived Fragments And The Genes They Regulate In Breast Cancer Progression And Metastasis. | 2020 |
| Salk Institute For Biological Studies | $75,000 | La Jolla, CA, US | To Investigate The Potential Of Ca19-9 As A Therapeutic Target For Pancreatic Cancer Treatment And To Discover Pharmacological Approaches To Blocking Ca19-9 Production In Malignant Cells. | 2020 |
| University Of California San Francisco | $150,000 | San Francisco, CA, US | To Develop A Small Molecule That Stabilizes Mutant P53 In Cancer And Further Elaborate This Compound With The Ability To Increase Dna Binding Of Bound P53. | 2020 |
| University Of Chicago | $75,000 | Chicago, IL, US | To Identify Combinations Of Commensal Bacterial Isolates That Suppress Klebsiella Pneumoniae In The Colon And The Underlying Cooperative Mechanisms Of This Activity. | 2020 |
| Georgetown University | $150,000 | Washington, DC, US | To Investigate How Usp-13, A Protein Involved In The Clearance Of Misfolded And Abnormal Proteins, May Function As A Regulator To Clear Proteins Implicated In The Development And Progression Of Neurodegenerative Diseases. | 2018 |
| Hackensack University Medical Center | $75,000 | Hackensack, NJ, US | To Evaluate Potential Therapies To Decrease Cell Adhesion Interaction-mediated Drug Resistance In Multiple Myeloma, A Type Of Hematological Cancer Characterized By The Uncontrollable Proliferation Of Plasma Immune Cells In The Bone Marrow. | 2018 |
| Regents Of The University Of California | $150,000 | La Jolla, CA, US | To (1) Define A Microbiome Growth Curce In Healthy Children, (2) Determine When And Why Deviation From This Curve Occurs, And (3) Investigate Known, As Well As Discover New, Microbiome-linked Disorders And Relationships Among Them. | 2018 |
| Loyola University Of Chicago | $150,000 | Maywood, IL, US | To Investigate How The Transfer Of Alpha-synuclein Between Cells In The Nervous System Induces Neuroinflammation That Drives Parkinson's Disease Pathogenesis. | 2018 |
| Regents Of The University Of Michigan | $75,000 | Ann Arbor, MI, US | To Study The Role Of A Protein Modification Process Known As Ampylation On Heat Shock Protein Function In The Onset, Development, And Progression Of Neurodegenerative Diseases (alzheimer's, Parkinson's, And Huntington Diseases) | 2018 |
| Regents Of The University Of Michigan | $150,000 | Ann Arbor, MI, US | To Develop A Novel Cancer Vaccine Using Artificial Virus-like Particles, And To Analyze Its Efficacy In The Development Of Anti-tumor Clearance, And Long-term Immunity. | 2018 |
| Rockefeller University | $150,000 | New York, NY, US | To Determine The Role Of Brca2 And Other Dna Repair Proteins, Which Are Important For Neural Progenitor Cells Of The Cerebellem, In The Development Of Medulloblastoma, The Most Common Pediatric Brain Malignancy. | 2018 |
| Salk Institute For Biological Studies | $150,000 | La Jolla, CA, US | To Analyze The Potential Therapeutic Effect Of Blocking Fatty Acid Synthesis In Non-small Cell Lung Cancer Through The Use Of Novel Enzymatic Inhibitors. | 2018 |
| Tisch Multiple Sclerosis Research Center Of New York Inc | $150,000 | New York, NY, US | To Elucidate The Cause Of Ms By Investigating 3 Synergistic Factors: 1) The Initial Trigger That Generates The Anitbody Response In Ms; 2) The Role Of Epstein - Barr Virus In The Development Of Autoimmunity In Ms; And 3) The Role Of Anti-myelin Antibodies In Sustaining The Ongoing Demyelination And Disease. | 2018 |
| Uc San Diego Foundation | $75,000 | La Jolla, CA, US | To Examine How The Downregulation Of Ednrb, A Gene Found To Be Selective' In The High Altitude Human Population, Can Preserve Cardiovascular Function During Acute Hyposia. | 2018 |
| Uc San Diego Foundation | $75,000 | La Jolla, CA, US | To Analyze Sequencing Data From Subjects Living In High Altitude Conditions In Kyrgystan With Or Without High Altitude Pulmonary Hypertension, In Order To Select And Screen Candidate Genes For The Development Of Pulmonary Hypertension. | 2018 |
| Hackensack University Medical Center | $75,000 | Hackensack, NJ, US | To Evaluate Potential Therapies To Decrease Cell Adhesion Interaction-mediated Drug Resistance In Multiple Myeloma, A Type Of Hematological Cancer Characterized By The Uncontrollable Proliferation Of Plasma Immune Cells In The Bone Marrow. | 2017 |
| Hospital For Special Surgery | $100,000 | New York, NY, US | To Examine How The Molecule Interferon Contributes To Altered Immune System Activation In Lupus Patients. | 2017 |
| Memorial Sloan-kettering Cancer Center | $150,000 | New York, NY, US | To Induce Activation Of Antigen Presenting Cells, Particularly, Dendritic Cells, In Order To Yield A Robust Anti-tumor T Cell Response At The Tumor Site And Increase Sensitivity To Immune Checkpoint Blockade. | 2017 |
| Rockefeller University | $150,000 | New York, NY, US | To Determine The Role Of Brca2 And Other Dna Repair Proteins, Which Are Important For Neural Progenitor Cells Of The Cerebellem, In The Development Of Medulloblastoma, The Most Common Pediatric Brain Malignancy. | 2017 |
| Salk Institute For Biological Studies | $150,000 | La Jolla, CA, US | To Analyze The Potential Therapeutic Effect Of Blocking Fatty Acid Synthesis In Non-small Cell Lung Cancer Through The Use Of Novel Enzymatic Inhibitors. | 2017 |
| Tisch Multiple Sclerosis Research Center Of New York Inc | $150,000 | New York, NY, US | To Elucidate The Cause Of Ms By Investigating 3 Synergistic Factors: 1) The Initial Trigger That Generates The Anitbody Response In Ms; 2) The Role Of Epstein - Barr Virus In The Development Of Autoimmunity In Ms; And 3) The Role Of Anot-myelin Antibodies In Sustaining The Ongoing Demyelination And Disease. | 2017 |
| Uc San Diego Foundation | $75,000 | La Jolla, CA, US | To Examine How The Downregulation Of Ednrb, A Gene Found To Be Selective' In The High Altitude Human Population, Can Preserve Cardiovascular Function During Acute Hyposia. | 2017 |
| Uc San Diego Foundation | $75,000 | La Jolla, CA, US | To Analyze Sequencing Data From Subjects Living In High Altitude Conditions In Kyrgystan With Or Without High Altitude Pulmonary Hypertension, In Order To Select And Screen Candidate Genes For The Development Of Pulmonary Hypertension. | 2017 |
| Uc San Diego Foundation | $100,000 | La Jolla, CA, US | To Investigate The Effects Of Intermittent Low Levels Of Blood Oxygen And High Levels Of Carbon Dioxide In The Development Of Atherosclerosis And Cardiovascular Disease. | 2017 |
| University Of Minnesota Foundation | $100,000 | Minneapolis, MN, US | To Investigate The Changes In Methylation Associated With Major Depressive Disorders. | 2017 |
| The Children's Hospital Corporation | $75,000 | Boston, MA, US | To Study The Role Of Protein Modification Process Known As Ampylation On Heat Shock Protein Funciton In The Onset, Development. And Progression Of Neurodegenerative Diseases (alzheimer's, Parkinson's, And Huntington's Diseases). | 2017 |
| Regents Of The University Of Michigan | $150,000 | Ann Arbor, MI, US | To Develop A Novel Cancer Vaccine Using Artificial Virus-like Particles, And To Analyze Its Efficacy In The Development Of Anti-tumor Clearance, And Long-term Immunity. | 2017 |
| Georgetown University | $150,000 | Washington, DC, US | To Investigate How Usp-13, A Proteisn Involved In The Clearance Of Misfolded And Abnormal Proteins, May Funciton As A Regulator To Clear Proteins Implicated In The Development And Progression Of Neurodegenerative Diseases. | 2017 |
| Loyola University Of Chicago | $150,000 | Maywood, IL, US | To Investigate How The Transfer Of Alpha-synuclein Between Cells In The Nervous System Induces Neuroinflammation That Drives Parkinson's Disease Pathogenesis. | 2017 |
| Hackensack University Medical Center | $75,000 | Hackensack, NJ, US | To Evaluate Potential Therapies To Decrease Cell Adhesion Interaction-mediated Drug Resistance In Multiple Myeloma, A Type Of Hematological Cancer Characterized By The Uncontrollable Proliferation Of Plasma Immune Cells In The Bone Marrow. | 2016 |
| Hospital For Special Surgery | $150,000 | New York, NY, US | To Examine How The Molecule Interferon Contributes To Altered Immune System Activation In Lupus Patients And To The High Prevalence Of Lupus In Females. | 2016 |
| Memorial Sloan-kettering Cancer Center | $150,000 | New York, NY, US | To Test The Efficacy Of "armored" Car T Cell Therapy, Which Uses A Patients Own T Cells To Fight Cancer, In Order To Enhance The Anti-tumor Immune Responses Of Patients With Relapsed Chronic Lymphocytic Leukemia (cll). | 2016 |
| Memorial Sloan-kettering Cancer Center | $150,000 | New York, NY, US | To Induce Activation Of Antigen Presenting Cells, Particularly, Dendritic Cells, In Order To Yield A Robust Anti-tumor T Cell Response At The Tumor Site And Increase Sensitivity To Immune Checkpoint Blockade. | 2016 |
| Rockefeller University | $150,000 | New York, NY, US | To Determine The Role Of Brca2 And Other Dna Repair Proteins, Which Are Important For Neural Progenitor Cells Of The Cerebellem, In The Development Of Medulloblastoma, The Most Common Pediatric Brain Malignancy. | 2016 |
| Salk Institute For Biological Studies | $150,000 | La Jolla, CA, US | To Investigate The Role Of Telomeres In Organizing Chromosomes Within The Cell And How This Ultimately Affects Aging And The Onset Of Age-associated Diseases. | 2016 |
| Whitehead Institute For Biomedical Research | $150,000 | Cambridge, MA, US | To Investigate The Role Of Alzheimer's Disease (ad) Risk Geners In The Interplay Between Neurons And Microglia, The Resident Immune Cells Of The Brain, In Order To Gain Novel Insights Into Both Disease Mechanisms And Potential Therapeutic Strategies For Ad. | 2016 |
| Tisch Multiple Sclerosis Research Center Of New York Inc | $150,000 | New York, NY, US | To Elucidate The Cause Of Ms By Investigating 3 Synergistic Factors: 1) The Initial Trigger That Generates The Anitbody Response In Ms; 2) The Role Of Epstein - Barr Virus In The Development Of Autoimmunity In Ms; And 3) The Role Of Anot-myelin Antibodies In Sustaining The Ongoing Demyelination And Disease. | 2016 |
| Uc San Diego Foundation | $75,000 | La Jolla, CA, US | To Examine How The Downregulation Of Ednrb, A Gene Found To Be Selective' In The High Altitude Human Population, Can Preserve Cardiovascular Function During Acute Hyposia. | 2016 |
| University Of Minnesota Foundation | $150,000 | Minneapolis, MN, US | To Understand How Dna Methylation Is Affected By Early Chronic Stress, And The Role That This Epigenetic Mechanism Has In The Emergence Of Psychopathology As Well As In Resilience To Adversity. | 2016 |
| Whitehead Institute For Biomedical Research | $75,000 | Cambridge, MA, US | To Study The Role Of Protein Modification Process Known As Ampylation On Heat Shock Protein Funciton In The Onset, Development. And Progression Of Neurodegenerative Diseases (alzheimer's, Parkinson's, And Huntington's Diseases). | 2016 |
| Uc San Diego Foundation | $75,000 | La Jolla, CA, US | To Analyze Sequencing Data From Subjects Living In High Altitude Conditions In Kyrgystan With Or Without High Altitude Pulmonary Hypertension, In Order To Select And Screen Candidate Genes For The Development Of Pulmonary Hypertension. | 2016 |
| Uc San Diego Foundation | $150,000 | La Jolla, CA, US | To Investigate The Effects Of Intermittent Low Levels Of Blood Oxygen And High Levels Of Carbon Dioxide, A Characteristic Of Obstructive Sleep Apnea Patients, On The Development Of Atherosclerosis And Cardiovascular Disease. | 2016 |
Foundations Similar to Emerald Foundation Inc
Discover 5 foundations with comparable assets ($28,910,882-$29,740,238), similar grant patterns, and geographic focus in NY that may also align with your organization's funding needs and grant seeking strategy.
| Foundation Name | Total Assets | Typical Grant Size | Service Area | Similarity Match |
|---|---|---|---|---|
|
The Arthur M Sackler Foundation
EIN: 52-1074954 | 8 grants awarded |
$29,360,795
(≈ Similar) |
$45,450
median grant |
New York, NY
Same state |
|
|
Schlumberger Foundation Inc
EIN: 23-7033142 | 217 grants awarded |
$29,083,096
(≈ Similar) |
$48,918
median grant |
New York, NY
Same state |
|
|
The Echo Street Foundation
EIN: 27-4017816 | 92 grants awarded |
$29,680,736
(≈ Similar) |
$40,000
median grant |
New York, NY
Same state |
|
|
The George G Fund
EIN: 85-6576699 | 62 grants awarded |
$29,740,238
(≈ Similar) |
$100,000
median grant |
New York, NY
Same state |
|
|
Bnai Sara Foundation Inc
EIN: 27-2868912 | 79 grants awarded |
$28,910,882
(≈ Similar) |
$50,000
median grant |
Brooklyn, NY
Same state |
|
Related Foundation Resources in NY:
Contact Information
Official contact details for Emerald Foundation Inc as registered with the IRS. These details are essential for grant applications, correspondence, and due diligence processes.
| EIN | 13-3912580 |
| Website | N/A |
| Address | 40 WALL ST 35TH FLR New York, NY 10005-0000 |
Key People (5)
Board members, trustees, and key staff who oversee Emerald Foundation Inc's grant making decisions and strategic direction. Understanding leadership composition can provide insights into foundation priorities and potential networking opportunities.
| Vice President | James P Mahaffey |
|---|---|
| Pres/director | Andrew W Heymann |
| Director | Luca Cantelli |
| Treasurer | William Blum |
| Director | Erika Kellerhals |
Forms 990-PF
IRS Form 990-PF filings provide comprehensive financial information, grant details, and operational data. These documents are essential resources for understanding foundation capacity, giving patterns, and strategic priorities.
Form 990-PF Research Tips
- Review Part XV for detailed grant recipient information and funding purposes
- Check Part I for total assets, annual giving amounts, and payout requirements
- Examine Part VIII for key personnel compensation and board structure
- Look for trends across multiple years to understand giving patterns
About This Foundation Profile
This comprehensive foundation profile for Emerald Foundation Inc is powered by Grant Bay's advanced foundation research platform. Our system analyzes IRS Form 990-PF filings, grant histories, and philanthropic patterns to provide nonprofit organizations with actionable intelligence for grant seeking success.
Data Sources & Accuracy
All information is derived from official IRS filings and public records. Grant Bay processes thousands of Form 990-PF documents to extract grant details, financial data, and organizational information. Data accuracy depends on foundation reporting quality and IRS filing completeness.
Research Applications
Use this profile for prospect research, grant strategy development, application preparation, and relationship building. Combine this data with additional research on foundation priorities, application processes, and board member backgrounds for comprehensive grant seeking strategies.
Data Currency: Last updated
March 2026
based on IRS Form 990-PF filings. Foundation information reflects most recent available tax year data.